Latest News

Myomo Announces One-for-Thirty Reverse Stock Split of its Common Stock

CAMBRIDGE, Mass.–(BUSINESS WIRE)–Myomo, Inc. (NYSE American: MYO), a commercial stage medical robotics company that offers expanded mobility for those suffering from neurological disorders and upper limb paralysis, today announced following approval of a reverse stock split range and authorized share reduction by stockholders at a special meeting of stockholders earlier today, Myomo’s Board of Directors determined to effect a reverse stock split of Myomo’s common stock at a ratio of one-for-t

Source link

Related posts

Study looks at changes in outcomes for coronary revascularization


Faced with an outcry over limits on opioids, authors of CDC guidelines acknowledge they’ve been misapplied


Does Medicaid managed care impact obstetrical care and birth outcomes?


This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy